Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Suh DJ et al. – The 48–week ETV treatment was less effective in LAM/ADV–resistant than in LAM–resistant patients. Continuing ETV monotherapy could be determined based on the virological response at 12 weeks in LAM/ADV–resistant patients.


Today in Stomach/GI...keeping you current

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin
Journal of Viral Hepatitis, 11/09/09

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address